Healthcare's "front door" is getting a technology overhaul. Every appointment booked, insurance card scanned, and prior authorization submitted is part of what the industry calls patient access — and the software and services that manage it have become one of the more closely watched corners of healthcare IT. The global patient access solutions market: 2024 market size: USD...

Patient support hubs have quietly become one of the most strategically important — and most contested — functions in pharmaceutical commercialization. For years, the model was simple: manufacturers launched a specialty drug, handed enrollment, reimbursement, and adherence support to a third-party hub vendor, and moved on. That playbook is now being rewritten. A wave of 2026...

In 2025, the conversation around Chronic Fatigue Syndrome (CFS) is finally evolving. After decades of being overlooked, this complex and disabling disorder is drawing new scientific and clinical attention. Once thought to be purely psychological or unmeasurable, CFS — or Myalgic Encephalomyelitis (ME/CFS) — is now recognized as a biological illness with immune,...

The arrival of the COVID “Nimbus” variant has triggered a surge of discussions across the United States. With this new COVID variant spreading faster than earlier strains, concerns about treatment strategies and healthcare accessibility are again in the spotlight. Among the most controversial topics resurfacing is Ivermectin USA debates. From hospitals and public...

The arrival of the COVID “Nimbus” variant has triggered a surge of discussions across the United States. With this new COVID variant spreading faster than earlier strains, concerns about treatment strategies and healthcare accessibility are again in the spotlight. Among the most controversial topics resurfacing is Ivermectin USA debates. From hospitals and public...